Aarti Drugs Ltd. announced that CRISIL has reaffirmed its long-term credit rating at CRISIL AA- with a stable outlook for its bank facilities amounting to Rs. 1,768 Crores, increased from Rs. 1,715 Crores. The short-term rating remains at CRISIL A1+.